Evidence map›Paper›PMID 30811388›Full record

Observational studyPLoS neglected tropical diseases2019

Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: An observational cohort study.

J Daniel Kelly, Sheri D Weiser, Barthalomew Wilson, Joseph B Cooper, Meekie Glayweon, Michael C Sneller, Clara Drew, Wayne T Steward, Cavan Reilly, Kumblytee Johnson and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

J Daniel KellyDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States of America.ORCID 0000-0002-7616-0321
Sheri D WeiserDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States of America.
Barthalomew WilsonU.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Joseph B CooperU.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Meekie GlayweonU.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Michael C SnellerLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States of America.
Clara DrewU.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Wayne T StewardDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States of America.
Cavan ReillyU.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Kumblytee JohnsonU.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Mosoka P FallahU.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Planned Parenthood Association of Liberia · LRUniversity of California, San Francisco · USUniversity of Minnesota · USNational Institute of Allergy and Infectious Diseases · US

Funding

Understanding the epidemiology and natural history of unrecognized Ebola virus infectionK23AI146268 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KELLY, JOHN DANIEL · 2019 to 2022
$748k
NIAID NIH HHS K23 AI146268
6 · The paper itself

Abstract

backgroundWhile qualitative assessments of Ebola virus disease (EVD)-related stigma have been undertaken among survivors and the general public, quantitative tools and assessment targeting survivors have been lacking. METHODS AND

findingsBeginning in June 2015, EVD survivors from seven Liberian counties, where most of the country's EVD cases occurred, were eligible to enroll in a longitudinal cohort. Seven stigma questions were adapted from the People Living with HIV Stigma Index and asked to EVD survivors over the age of 12 at initial visit (median 358 days post-EVD) and 18 months later. Primary outcome was a 7-item EVD-related stigma index. Explanatory variables included age, gender, educational level, pregnancy status, post-EVD hospitalization, referred to medical care and EVD source. Proportional odds logistic regression models and generalized linear mixed-effects models were used to assess stigma at initial visit and over time. The stigma questions were administered to 859 EVD survivors at initial visit and 741 (86%) survivors at follow-up. While 63% of survivors reported any stigma at initial visit, only 5% reported any stigma at follow-up. Over the 18-month period, there was a significant decrease in stigma among EVD survivors (Adjusted Odds Ratio [AOR], 0.02; 95% Confidence Interval [CI], 0.01-0.04). At initial visit, having primary, junior high or vocational education, and being referred to medical care was associated with higher odds of stigma (educational level: AOR, 1.82; 95%CI, 1.27-2.62; referred: AOR, 1.50; 95%CI, 1.16-1.94). Compared to ages of 20-29, those who had ages of 12-19 or 50+ experienced lower odds of stigma (12-19: AOR, 0.32; 95%CI, 0.21-0.48; 50+: AOR, 0.58 95%CI, 0.37-0.91).

conclusionsOur data suggest that EVD-related stigma was much lower more than a year after active Ebola transmission ended in Liberia. Among survivors who screened negative for stigma, additional probing may be considered based on age, education, and referral to care.

Indexed as

Social StigmaAdolescentAdultCohort StudiesDisease OutbreaksFemaleHemorrhagic Fever, EbolaHumansLiberiaLogistic ModelsMaleMiddle AgedOdds RatioPregnancySurveys and QuestionnairesSurvivors

Identifiers

PMID30811388
PMCPMC6411197
OpenAlexW2915308947

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.